nandrolone
โ Previous: nalorphine | ๐ All Substances | ๐ Complete Table | Next: naphthalene โ
OPSS Properties
| Classifications | 6000 |
| DEA Schedule | Schedule III |
| Reason | Controlled substance: Schedule III |
| Also Known As |
|
| Prohibited Because | DEA Controlled Substance List: Schedule III (DEA Controlled Substance List: Schedule III) WADA S1: Anabolic Agents (WADA Prohibited List S1: Anabolic Agents) |
| Label Terms | ["19-norandrost-4-ene-3b-ol, 17-one decanoate", "19-norandrost-4-ene-3b-ol, 17-one enanthate"] |
| Added to Database | December 30, 2025 |
| Source Last Updated | September 30, 2024 |
| GUID | 93509201-9243-4125-ab18-9f8e9b5589a5 |
External Resources
- FDA UNII Search
- GSRS Full Record
- NCATS Inxight Drugs
- CAS Common Chemistry
- PubChem
- EPA CompTox Dashboard
UNII: 6PG9VR430D ยท CAS: 434-22-0
PubChem Properties
Chemical Structure
Interactive 3D Structure
| Molecular Formula | C18H26O2 |
| Molecular Weight | 274.4 g/mol |
| IUPAC Name | (8R,9S,10R,13S,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one |
| InChIKey | NPAGDVCDWIYMMC-IZPLOLCNSA-N |
๐ Complete Table | ๐ All Substances
Substance 623 of 880